a16z Bio + Health #18: What will it take to cure diabetes?

Nearly one in seven Americans has diabetes, but our understanding of the disease has long been limited to two types (Type 1 and Type 2) with a focus on glucose and insulin. But breakthroughs in insulin delivery, glucose monitoring, stem cell therapies, and other diabetes treatments are helping to debunk misconceptions of diabetes as a lifestyle disease and evolving the ways we fight it. So, what is the current landscape of treatments? And what more will it take to cure diabetes? The a16z Bio team talks to Doug Melton (Harvard Stem Cell Institute) and Aaron Kowalski (CEO of JDRF).

Om Podcasten

a16z Live is the place to listen to recorded live discussions and events featuring, hosted, or co-hosted by a16z partners (with outside voices too). As a reminder, all content posted here is provided for informational purposes only, and should not be relied upon as legal, business, investment, or tax advice. Views expressed are those of the individuals and not the views of Andreessen Horowitz, please see a16z.com/disclosures for more. To learn more about the broader a16z Podcast network and shows, please visit a16z.com/podnetwork.